These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 18991509)

  • 1. Iatrogenic Cushing syndrome after epidural triamcinolone injections in an HIV type 1-infected patient receiving therapy with ritonavir-lopinavir.
    Ramanathan R; Pau AK; Busse KH; Zemskova M; Nieman L; Kwan R; Hammer JH; Mican JM; Maldarelli F
    Clin Infect Dis; 2008 Dec; 47(12):e97-9. PubMed ID: 18991509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iatrogenic Cushing syndrome after intra-articular triamcinolone in a patient receiving ritonavir-boosted darunavir.
    Hall JJ; Hughes CA; Foisy MM; Houston S; Shafran S
    Int J STD AIDS; 2013 Sep; 24(9):748-52. PubMed ID: 23970582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Orbital floor triamcinolone causing Cushing's syndrome in a patient treated with Kaletra for HIV 1.
    McConkey HZ; Williams H; Kulasegaram R; Graham E
    BMJ Case Rep; 2013 Feb; 2013():. PubMed ID: 23440982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ritonavir and epidural triamcinolone as a cause of iatrogenic Cushing's syndrome.
    Albert NE; Kazi S; Santoro J; Dougherty R
    Am J Med Sci; 2012 Jul; 344(1):72-4. PubMed ID: 22543594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iatrogenic hypercortisolism complicating triamcinolone acetonide injections in patients with HIV on ritonavir-boosted protease inhibitors.
    Fessler D; Beach J; Keel J; Stead W
    Pain Physician; 2012; 15(6):489-93. PubMed ID: 23159966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic derangement after injection of triamcinolone into the hip of an HIV-infected patient receiving ritonavir.
    Danaher PJ; Salsbury TL; Delmar JA
    Orthopedics; 2009 Jun; 32(6):450. PubMed ID: 19634808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iatrogenic Cushing syndrome after epidural steroid injections for lumbar radiculopathy in an HIV-infected patient treated with ritonavir: a case report highlighting drug interactions for spine interventionalists.
    Grierson MJ; Harrast MA
    PM R; 2012 Mar; 4(3):234-7. PubMed ID: 22443962
    [No Abstract]   [Full Text] [Related]  

  • 8. Iatrogenic Cushing's syndrome after triamcinolone plus ritonavir-boosted atazanavir.
    Jakeman B; Conklin J; Bouchonville M; Thornton K
    J Am Pharm Assoc (2003); 2015; 55(2):193-7. PubMed ID: 25658506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iatrogenic Cushing syndrome and secondary adrenal insufficiency related to concomitant triamcinolone and ritonavir administration: a case report and review.
    Song Y; Schroeder JR; Bush LM
    J Int Assoc Provid AIDS Care; 2014; 13(6):511-4. PubMed ID: 25513635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iatrogenic Cushing syndrome and secondary adrenal insufficiency related to concomitant triamcinolone and ritonavir administration: a case report and review.
    Song Y; Schroeder JR; Bush LM
    J Int Assoc Provid AIDS Care; 2014; 13(6):511-4. PubMed ID: 23778239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triamcinolone and ritonavir leading to drug-induced Cushing syndrome and adrenal suppression: description of a new case and review of the literature.
    Schwarze-Zander C; Klingmüller D; Klümper J; Strassburg CP; Rockstroh JK
    Infection; 2013 Dec; 41(6):1183-7. PubMed ID: 23873267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lopinavir-ritonavir versus nelfinavir for the initial treatment of HIV infection.
    Walmsley S; Bernstein B; King M; Arribas J; Beall G; Ruane P; Johnson M; Johnson D; Lalonde R; Japour A; Brun S; Sun E;
    N Engl J Med; 2002 Jun; 346(26):2039-46. PubMed ID: 12087139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Insulin resistance in HIV-infected patients receiving long-term therapy with efavirenz, lopinavir/ritonavir and atazanavir].
    Bernal E; Masiá M; Padilla S; Ramos JM; Martín-Hidalgo A; Gutiérrez F
    Med Clin (Barc); 2007 Jul; 129(7):252-4. PubMed ID: 17683706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Injecting epidural and intra-articular triamcinolone in HIV-positive patients on ritonavir: beware of iatrogenic Cushing's syndrome.
    Maviki M; Cowley P; Marmery H
    Skeletal Radiol; 2013 Feb; 42(2):313-5. PubMed ID: 23151875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lopinavir/ritonavir maintenance monotherapy after successful viral suppression with standard highly active antiretroviral therapy in HIV-1-infected patients.
    Campo RE; Lalanne R; Tanner TJ; Jayaweera DT; Rodriguez AE; Fontaine L; Kolber MA
    AIDS; 2005 Mar; 19(4):447-9. PubMed ID: 15750401
    [No Abstract]   [Full Text] [Related]  

  • 16. Adrenal insufficiency due to ritonavir-triamcinolone drug-drug interaction without preceding Cushing's syndrome.
    Noe S; Jaeger H; Heldwein S
    Int J STD AIDS; 2018 Nov; 29(11):1136-1139. PubMed ID: 29749880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secondary adrenal insufficiency from steroid use and co-prescribing of cytochrome p450 3A4 inhibitors.
    Williams D; Reicher I; Mohammed H; Richardson D
    HIV Med; 2019 May; 20(5):e10-e11. PubMed ID: 30924569
    [No Abstract]   [Full Text] [Related]  

  • 18. Once-daily atazanavir/ritonavir versus twice-daily lopinavir/ritonavir, each in combination with tenofovir and emtricitabine, for management of antiretroviral-naive HIV-1-infected patients: 48 week efficacy and safety results of the CASTLE study.
    Molina JM; Andrade-Villanueva J; Echevarria J; Chetchotisakd P; Corral J; David N; Moyle G; Mancini M; Percival L; Yang R; Thiry A; McGrath D;
    Lancet; 2008 Aug; 372(9639):646-55. PubMed ID: 18722869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and antiviral response at 12 months of lopinavir/ritonavir therapy in human immunodeficiency virus-1-infected children experienced with three classes of antiretrovirals.
    Ramos JT; De José MI; Dueñas J; Fortuny C; González-Montero R; Mellado MJ; Mur A; Navarro M; Otero C; Pocheville I; Muñoz-Fernández MA; Cabrero E;
    Pediatr Infect Dis J; 2005 Oct; 24(10):867-73. PubMed ID: 16220083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absence of HIV-1 shedding in male genital tract after 1 year of first-line lopinavir/ritonavir alone or in combination with zidovudine/lamivudine.
    Ghosn J; Chaix ML; Peytavin G; Bresson JL; Galimand J; Girard PM; Raffi F; Cohen-Codar I; Delfraissy JF; Rouzioux C
    J Antimicrob Chemother; 2008 Jun; 61(6):1344-7. PubMed ID: 18343806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.